| Malignant Nervous System Neoplasm studied in …STUDIED_INderived200 of 3,457show all (up to 200) |
|---|
| → studied in | NCT00924196active not recruiting Natural History Study of Patients With Neurofibromatosis Type I · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04724369Phase 3 · completed Open-Label Study of 18F-mFBG for Imaging Neuroblastoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05685004Phase 2/Phase 3 · active not recruiting Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM) · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05864534Phase 2 · active not recruiting Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05871021Phase 2 · active not recruiting Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05902169Phase 3 · recruiting Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06325683Phase 2 · suspended Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06479811Phase 1 · recruiting [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Olfactory Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07374692completed Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Malignant Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07492316Phase 1 · active not recruiting RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB) · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01109394recruiting Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01445288completed Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05303467Phase 1 · recruiting A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05432804Phase 1/Phase 2 · recruiting Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07145112Phase 1 · recruiting Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07326566Phase 2 · recruiting Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07346157Phase 1/Phase 2 · recruiting Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07416188Phase 1/Phase 2 · recruiting Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07839247Phase 2 · recruiting Zanubrutinib Plus Lenalidomide for Frail Elderly Patients With Newly Diagnosed PCNSL · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03896568Phase 1 · recruiting MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Anaplastic Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05099003Phase 1/Phase 2 · recruiting A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG) · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05183204Phase 2 · completed Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07195591Phase 3 · recruiting Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07422896Phase 1 · not yet recruiting A Phase I First-in-human Trial of Bvax (B-cell Vaccination) in Addition to Standard of Care Chemoradiotherapy for Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07842835not yet recruiting Registry of an Integrated Longitudinal Multimodal Biospecimen Biobank for Primary CNS Lymphoma in China (CLIMB) · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02040376Phase 3 · completed Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04115761Phase 2 · recruiting Evaluate the Efficacy and Safety of ADCV01 as an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04868799completed Finding New Targets by Proteomic Approaches (InnovRT1) · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Atypical Teratoid/Rhabdoid Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05230758Phase 3 · recruiting Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Childhood Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05635734Phase 1/Phase 2 · completed Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06047379Phase 1/Phase 2 · recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06172296Phase 3 · recruiting Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Ganglioneuroblastoma, Nodular | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06462222Phase 1/Phase 2 · active not recruiting Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06995872Phase 1 · recruiting Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07225491recruiting Spine Oncology Registry · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Malignant Spinal Cord Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07568782not yet recruiting Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Immune Response in Glioblastoma: A Kinetic Analysis of Immune Biomarkers. · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03174197Phase 1/Phase 2 · completed Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04222413Phase 1 · recruiting Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04684368Phase 2 · recruiting A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Pineal Region Yolk Sac Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04729959Phase 2 · active not recruiting Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04837547Phase 1 · active not recruiting PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05353530Phase 1 · active not recruiting IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06175000Phase 2 · recruiting Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06389591Phase 1 · recruiting RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM) · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06485310NA · withdrawn Interest of a TEteleconsultation of a Psychological Support Nurse on Psychological Distress in Patients With a Primary Malignancy of the Central Nervous System · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Malignant Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06558214Phase 2 · recruiting OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07031765Phase 1 · active not recruiting Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Anaplastic Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07515924early Phase 1 · not yet recruiting Oral Gallium Maltolate for Recurrent Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07708961Phase 2 · suspended Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07821112Phase 2 · not yet recruiting Phase II Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Treated With Cesium-131 GammaTile® · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07830134NA · recruiting Cognitive Rehabilitation for Survivors of Childhood Medulloblastoma Using Real Time Hemodynamic Neurofeedback · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Childhood Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01005654recruiting Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01857934Phase 2 · completed Therapy for Children With Advanced Stage Neuroblastoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03197506Phase 2 · active not recruiting Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Childhood Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03251989completed Rare CNS Tumors Outcomes &Risk · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03528642Phase 1 · active not recruiting Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Astrocytoma, IDH-Mutant, Grade 3 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05109728Phase 1 · active not recruiting A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent. · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05555550early Phase 1 · recruiting Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05765812Phase 1/Phase 2 · recruiting A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Anaplastic Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06814496Phase 1/Phase 2 · recruiting Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Olfactory Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07703436Phase 2 · not yet recruiting Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Astrocytoma, IDH-Mutant, Grade 3 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07832448NA · active not recruiting Microsurgical Resection Combined With Photodynamic Therapy for Recurrent Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07833631completed A Prospective Image Reevaluation Study to Assess the Efficacy of 18F-mFBG PET Imaging in Subjects With Neuroblastoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07833657Phase 2 · not yet recruiting Combined Intrathecal and Systemic Therapy With Trastuzumab Rezetecan for Leptomeningeal Metastases · condition mapped PROBABILISTIC · 3,457 trials mapped (1,112 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03223103Phase 1 · active not recruiting Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03698994Phase 2 · active not recruiting Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04977375Phase 1/Phase 2 · recruiting Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06176989Phase 2 · recruiting Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Olfactory Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06804655Phase 2 · recruiting Pharmacoscopy for Patients With Refractory Primary Brain Tumors · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06838676Phase 2 · recruiting ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831161NA · not yet recruiting Safety and Efficacy of Autologous Natural Killer Cell Therapy (CHANK-101) in Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831187Phase 1/Phase 2 · not yet recruiting Entacapone Plus Bevacizumab for Glioblastoma at First Recurrence · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831369Phase 2 · recruiting VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831772NA · recruiting REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03587038Phase 1 · active not recruiting OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05077735Phase 2 · active not recruiting Stereotactic Biopsy Split-Course Radiation Therapy in Diffuse Midline Glioma, SPORT-DMG Trial · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07089641Phase 1 · recruiting ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07298083recruiting DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07827001recruiting PilotStudyAssessSafeActiveSurveillancApproachLocalThe Pa w/BrainMetsUndergoinCNSPenetratSystemicThe · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Malignant Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03277638Phase 1/Phase 2 · completed Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM) · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Adult Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04688151Phase 1 · completed Rituximab, Acalabrutinib, and Durvalumab (RAD) in Primary CNS Lymphoma. · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05421897Phase 2 · active not recruiting Rapid Administration Pilot for Infusing Dinutuximab · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06395103Phase 1/Phase 2 · recruiting Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01) · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06816927Phase 2 · recruiting Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07537400Phase 2 · recruiting Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5 · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02974738Phase 1 · active not recruiting A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001) · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03535350Phase 1 · active not recruiting Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04211675Phase 1/Phase 2 · active not recruiting NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04462328Phase 1 · active not recruiting Acalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06858501Phase 2 · withdrawn Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02974621Phase 2 · active not recruiting Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03016156NA · terminated Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Retinoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03115333NA · active not recruiting DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05495295Phase 1 · active not recruiting First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05535166Phase 2 · recruiting Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06129760NA · suspended Glioblastoma Remote Monitoring and Care - Research Protocol · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06132438Phase 1 · recruiting Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06357377Phase 1 · recruiting A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07389278Phase 1/Phase 2 · not yet recruiting Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG) · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07819838Phase 1/Phase 2 · not yet recruiting Testing the Addition of an Anti-Cancer Drug, Daraxonrasib, for Relapsed or Refractory Solid Tumors With RAS Mutations · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Childhood Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02704858Phase 1/Phase 2 · active not recruiting Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04771806recruiting Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05698524Phase 1 · recruiting A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Anaplastic Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06674811recruiting Biomarkers of Resiliency In Childhood Cancer Surgery · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06797661NA · recruiting Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients With Brain Lesions. · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04870944Phase 1/Phase 2 · recruiting CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Diffuse Midline Glioma, H3 K27-Altered | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06639607Phase 1/Phase 2 · suspended PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Diffuse Midline Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07087002Phase 1 · recruiting GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05027386Phase 1/Phase 2 · completed Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Neuroblastoma: A Single-arm, Phase I/II，Multi-center, Clinical Study. · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05052957Phase 2 · recruiting hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM) · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07349693Phase 2/Phase 3 · not yet recruiting Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07452458Phase 3 · recruiting Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07811297Phase 1/Phase 2 · not yet recruiting A Study of Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02847559Phase 2 · completed Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03212274Phase 2 · active not recruiting Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04899908Phase 2 · recruiting Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Malignant Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05139056Phase 1 · recruiting Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06329570Phase 1/Phase 2 · suspended Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM) · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06410248Phase 1 · recruiting Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma, IDH-Wildtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06613841early Phase 1 · recruiting Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06934889Phase 1 · recruiting Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06946680Phase 1 · not yet recruiting IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG) · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06989086NA · recruiting FearLess in NeuroOncology · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07437963Phase 1/Phase 2 · not yet recruiting Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07467109recruiting A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Malignant Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07644312Phase 2 · not yet recruiting Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPG · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07809178not yet recruiting China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Germinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03952598Phase 2 · suspended Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05839379recruiting Targeted Pediatric High-Grade Glioma Therapy · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01711554Phase 1 · active not recruiting Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02559778Phase 2 · recruiting Pediatric Precision Laboratory Advanced Neuroblastoma Therapy · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02981940Phase 2 · active not recruiting A Study of Abemaciclib in Recurrent Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03911388Phase 1 · recruiting HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Malignant Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03964090Phase 2 · active not recruiting Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS) · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04609046Phase 1 · active not recruiting Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04991870Phase 1 · recruiting Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06894225Phase 2 · recruiting Proof-of-Concept Study of ACT001 in Adult Patients With Recurrent Glioblastoma Harbouring STAT3-High Signature · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02337686Phase 2 · active not recruiting Pembrolizumab in Treating Patients With Recurrent Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02679144Phase 2 · active not recruiting Neuroblastoma Maintenance Therapy Trial · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03657576Phase 1 · completed Trial of C134 in Patients With Recurrent GBM · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04301843Phase 2 · active not recruiting Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04677049Phase 1/Phase 2 · active not recruiting Study of Niacin in Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06465199Phase 1/Phase 2 · recruiting Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Atypical Teratoid/Rhabdoid Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06540963Phase 2 · recruiting Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541262Phase 1/Phase 2 · recruiting Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06959979early Phase 1 · recruiting Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Childhood Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07356973Phase 2 · recruiting Irinotecan-ChemoSeed in Surgically Resectable Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07358260Phase 1 · recruiting B7-H3.CD28Z.CART in Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07384884NA · recruiting Surgery and Laser Interstitial Thermal Therapy for Bilateral Glioblastomas · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07390539Phase 1 · recruiting B7-H3.CD28Z.CART in CNS Neoplasms · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04188535NA · recruiting Serial MRI Scans During Radiation Therapy · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05245500Phase 1 · recruiting Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06762080Phase 1/Phase 2 · active not recruiting Intrathecal Combination of Programmed Death-1 (PD-1)/Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Bispecific Antibody and Pemetrexed for Leptomeningeal Metastasis · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06809530Phase 1/Phase 2 · active not recruiting Intrathecal Dual Checkpoint Inhibitor (PD-1 and CTLA-4) in Combination With Pemetrexed for Leptomeningeal Metastasis · condition mapped PROBABILISTIC · 3,457 trials mapped (1,112 active) | — | — | Meningeal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06860594Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Adult Diffuse Hemispheric Glioma, H3 G34-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07215910Phase 3 · recruiting Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Astrocytoma, IDH-Mutant, Grade 3 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01875601Phase 1 · completed NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02114229Phase 2 · active not recruiting Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Atypical Teratoid/Rhabdoid Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04637503Phase 1/Phase 2 · not yet recruiting 4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06161974Phase 2 · recruiting Study of Olutasidenib and Temozolomide in HGG · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Anaplastic Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07180927Phase 1/Phase 2 · not yet recruiting DLL3 CAR-T Therapy Targeting Brain Tumors · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Cerebellar Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07242963recruiting Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04145115Phase 2 · active not recruiting A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Astrocytoma, IDH-Mutant, Grade 4 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04201873Phase 1 · completed Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05226494Phase 1 · active not recruiting Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06515860enrolling by invitation Neurofibromatosis Type 1 Tumor Early Detection Study · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Malignant Peripheral Nerve Sheath Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07796061Phase 1 · not yet recruiting Blood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination With T-Cell Infusion in Patients With Newly Diagnosed Diffuse Midline Glioma (LIFT) · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02142803Phase 1 · active not recruiting TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Adult Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02179086Phase 2 · active not recruiting Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02203526Phase 1 · active not recruiting Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02851706completed Natural History of and Specimen Banking for People With Tumors of the Central Nervous System · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Malignant Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04181684NA · active not recruiting LITT Followed by Hypofractionated RT for Recurrent Gliomas · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05303519Phase 3 · recruiting SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Astrocytoma, IDH-Mutant, Grade 3 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06528496Phase 2 · recruiting N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07420543active not recruiting Clinical Significance of Liquid Biopsy in Brain Tumor Patients: a 5-ALA Guided Approach · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781852early Phase 1 · not yet recruiting Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03975829Phase 4 · active not recruiting Pediatric Long-Term Follow-up and Rollover Study · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Anaplastic Astrocytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04464200Phase 1 · active not recruiting 19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Primary Central Nervous System Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07409584recruiting Mental Health and Suicidality in Glioblastoma Patients in Germany · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07501156Phase 1/Phase 2 · not yet recruiting H3K27M-specific Immune Effector Cells Targeting DMG/DIPG · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07789379Phase 2 · not yet recruiting Adebrelimab Plus Temozolomide ± Hyperbaric Oxygen for Primary Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07789938NA · not yet recruiting Intraoperative Neurophysiological Monitoring in Brain Tumor Surgery: Prospective Cohort Studies · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Malignant Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07791264Phase 1 · not yet recruiting FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05219149completed CNS Qualitative Interview · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Malignant Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05236036Phase 1 · active not recruiting Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05857969Phase 1 · recruiting Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Childhood Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06557512NA · recruiting Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma · condition mapped ALIAS · 3,457 trials mapped (1,112 active) | — | — | Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06701812Phase 2 · recruiting Digoxin Medulloblastoma Study · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07778602early Phase 1 · not yet recruiting Safety and Feasibility of First-line Avutometinib and Defactinib in Patients With Newly Diagnosed High-grade Gliomas · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | MGMT-Unmethylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07788430NA · not yet recruiting Impact of Pesticide Exposure on Survival and Tumor Aggressiveness in Patients With Glioblastoma: A Prospective Clinical Study · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02176967Phase 3 · active not recruiting Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03126916Phase 3 · recruiting Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03959085Phase 3 · recruiting Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Central Nervous System Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04851119Phase 1/Phase 2 · recruiting Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05039281Phase 1/Phase 2 · active not recruiting Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05382338Phase 3 · recruiting A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Childhood Medulloblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05504291Phase 2 · recruiting A Study to Give Treatment Inside the Eye to Treat Retinoblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Retinoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06368817Phase 2 · recruiting A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma · condition mapped ONTOLOGY_EXACT · 3,457 trials mapped (1,112 active) | — | — | Basal Ganglia Germinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07076472early Phase 1 · recruiting Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma · condition mapped CURATED_BROADER · 3,457 trials mapped (1,112 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |